The Super Rich: Start from when the family business is about to go bankrupt!

Chapter 310 WPG0309: Is this favorability still okay? Share project? 334K Please subscribe

An Wuyang did not delve into why Gu Mingyue pretended to like women. Why did he study this?
He is more worried now whether Gu Mingyue likes him, okay?
An Wuyang hopes that this is an illusion of life.
To be on the safe side, An Wuyang secretly used the character rating subsystem to check Gu Mingyue's rating information.

……

Gu Mingyue:
Age: 27
Height: 174cm
Weight: XNUM X kg
Face value: 90
Body: 84
Favorability: 69 ——> 80
Health: 90
Purity: 100
……

Is this favorability still okay?

Favorability ratings cannot be faked!
An Wuyang wondered what this Gu Mingyue meant.
Do you really want to feed old grass to young cows?
To An Wuyang, Gu Mingyue is of the royal sister type of age.

If she was just a queen, An Wuyang would choose to ignore her age, considering Gu Mingyue's beauty that is one in a million and her 100% purity.

But Gu Mingyue's identity will bring too much trouble!

First of all, Gu Mingyue is from the second level of the Imperial Capital Circle. Although Wu Gengtian has grown rapidly at present, he is still far from the level of the second level of the Imperial Capital Circle.

Secondly, Gu Mingyue pretended to like girls on the surface. An Wuyang didn't know the hidden truth, and he was not going to get involved.

Finally, there is the most troublesome origin problem.

An Wuyang is now with Xia Yuqing. Through An Wuyang's testing and analysis, he has basically understood Xia Yuqing's attitude.

If I want to be with Gu Mingyue, I'm afraid I can only be with Gu Mingyue, right?
So An Wuyang became secretly alert.

Boys must protect themselves outside!
While An Wuyang was secretly checking Gu Mingyue's character rating, Chen Hongzhi returned to the box.

An Wuyang looked over.

Chen Hongzhi had an embarrassed expression. He sighed and said, "Sorry, Brother Wuyang, our family does not agree to invest in the carbon transformation team."

Chen Hongzhi added, "Our family is not optimistic about the profit prospects of the carbon change team."

In fact, the Chen family also analyzed that the Carbon Change team might be defined by Wugengtian as a pure R&D team and it would be difficult for them to make a profit.

These families in the imperial capital are all very smart, otherwise how could they survive?
A moment later, Lin Qianli and Xu Le came back together. The attitudes of the two families were almost the same as those of the Chen family.

Chen Hongzhi added, "Brother Wuyang, regarding Professor Wei Zhenghong's lupus erythematosus project, does your company need investment?"

"Are you interested?" An Wuyang asked back.

Chen Hongzhi answered affirmatively, "I am indeed interested!"

“Compared with the Carbon Change team, we are more optimistic about the prospects of Professor Wei Zhenghong’s team’s project, or we can say that we believe in your strength and potential at Wugengtian,” Chen Hongzhi added.

Lin Qianli seconded the proposal, "If the lupus erythematosus project accepts investment, our Lin family is also ready to invest."

Xu Le replied, "Add us!"

"If you want to invest in the lupus project, it's actually not impossible." An Wuyang first set the tone, indicating that the lupus project is open to investment.

"But just like the Carbon Change team, we at Wugengtian will set up an AB share plan with equal shares but different voting rights. You only have the right to dividends, not management rights." An Wuyang first explained the first restriction.

"Secondly, even if the drug for treating lupus erythematosus is successfully developed, it will also be incorporated into the system channels of Wugengtian Pharmaceutical Group." An Wuyang added.

"This means that the pricing rights and sales plans of the corresponding drugs are all decided by us at Wugengtian." An Wuyang explained.

"Third, we at Wugengtian will not add more dealer quotas at this time." An Wuyang released the good news about stabilizing the top five dealers.

Although An Wuyang does not accept the five major distributors to further deepen their relationship with Wugengtian, he will not allow the five major distributors system to collapse.

After all, the five major distributors have become Wugengtian’s biggest moat!
Look at the treatment An Wuyang received in Tianfu, Shanghai, and the Imperial Capital?

The dealer representative treats An Wuyang like his father!

How could An Wuyang possibly give up his martial arts?

"The last and most crucial point is that if the drug for lupus erythematosus is successfully developed and if the cost of raw materials is not too high, then when it comes to pricing, we will refer more to Shuxin Pills." An Wuyang explained.

What this sentence means is that the final price of the corresponding drug may be relatively low, rather than reaping the wealth of a specific group of people through high drug prices.

After An Wuyang took over Wugengtian, he chose a diversified pricing plan for Wugengtian's products.

For example, the Ningzhi Ruoxue series of products are cosmetics, which are not essential products and are positioned more as high-end luxury goods, so their prices have always been very expensive.

After all, An Wuyang never thought that ordinary people would buy the Ningzhi Ruoxue series of products.

Another example is Ba Chun Xiao and Liang Huan Xi. Given the scarcity of raw materials and the fact that Wu Geng Tian Pharmaceutical Group has monopolized the supply chain of raw materials, and the fact that they are also non-essential products, their prices are extremely expensive.

However, when it came to Shuxin Pills, given that Shuxin Pills could be made using purchased materials and that the customers they were targeting might have limited financial conditions, the price of Shuxin Pills was only 79 yuan.

The Wugengtian Group, headed by An Wuyang, prefers to reap the wealth of the rich rather than squeeze oil from the poor.

Now the lupus project and the Shuxin Pills project actually have similarities.

There are approximately five to six million lupus patients worldwide, and about one million in Xia Country.

An Wuyang must consider a reasonable price so that most people can afford it while ensuring the interests of the Wugengtian Pharmaceutical Group.

Faced with the conditions stated by An Wuyang and the corresponding subtext, everyone fell silent again.

In the end, it was still Chen Hongzhi who asked first, "Brother Wuyang, do you know about Professor Wei Zhenghong's lupus erythematosus project?"

"We have investigated some situations, but overall we still don't know much about them. If you want to ask us about our assessment of the research and development prospects of lupus erythematosus, I can only say that there is little hope." An Wuyang sighed.

"After all, we all know that Professor Wei Zhenghong has been conducting research for twelve years with the support of the Imperial Capital Medical University, but ultimately failed and exhausted the patience of the Imperial Capital Medical University." An Wuyang added.

"From my personal point of view, I am not optimistic about this project." An Wuyang expressed his personal opinion.

"But from the perspective of Wu Geng Tian and my father, we at Wu Geng Tian will definitely invest in this project." An Wuyang added.

Chen Hongzhi asked, "What about the investment intensity?" "At least it's a youth version of the Double Tenth Law," An Wuyang replied.

There is a so-called "double ten rule" in the field of pharmaceutical research and development, which means that it usually takes more than 10 years and more than US$10 billion to develop a new drug.

As for the "youth version" mentioned by An Wuyang, it means that the R&D funds invested will be changed from 10 billion US dollars to 10 billion Xia Guoyuan.

This is also the feedback information given by the previous happy life system.

"Our Wugengtian Pharmaceutical Group will give Professor Wei Zhenghong's team at least 10 years and no less than 10 billion Xia Guoyuan in research and development funds to study the lupus erythematosus project." An Wuyang explained in detail.

"Another ten billion?" Chen Hongzhi was a little helpless.

Lin Qianli was also helpless, "So many?"

"Even if we invested 10 billion, there might not be any results. It's even very likely that all the money would go to waste," An Wuyang complained.

An Wuyang sighed and added, "This is the biggest difficulty in medical research and development!"

"Just like the Imperial Capital Medical University invested in Professor Wei Zhenghong's team for twelve years, but it ended in failure in the end," An Wuyang gave an example.

Chen Hongzhi complained, "It turns out that the difficulty of developing innovative drugs is so high. No wonder these pharmaceutical companies are unwilling to develop new drugs and prefer to directly make generic drugs."

An Wuyang joked, "It should be said that they make generic drugs that do not meet quality standards!"

"After all, the technical difficulty of generic drugs is also very high. It is also very difficult to obtain the [Generic Drug Consistency Evaluation], okay?" An Wuyang continued to tease.

Hundreds of pharmaceutical companies produce generic cephalosporins, but only a handful of them have obtained the [Generic Drug Consistency Evaluation].

This is outrageous!

When we donated medicines to the Nigel brothers, the medicines from a certain country were rejected by the Universal Alliance. Now everyone understands this, right?
This is the origin of the joke "Quisanti won't take medicines from a certain country"!
"The prospects of the lupus project are actually as unclear as those of the carbon change team. Does anyone still want to invest?" An Wuyang asked.

Xu Le continued, "If the drug for lupus erythematosus is successfully developed, will you Wugengtian still set two prices for domestic and overseas markets like Shuxin Pills?"

"First of all, let me make it clear that it is not us at Wugengtian who want to implement two prices, but the seven major overseas distributors of Wugengtian who implement two prices themselves!" An Wuyang instinctively threw the blame.

Some things have to be done, but you must never admit it!
Seeing An Wuyang throwing the pot, everyone couldn't help but burst into laughter.

Taking Shuxin Pills as an example, the ex-factory price obtained by the five major domestic distributors is 52 Xia Guoyuan, while the ex-factory price given by Wugengtian to the seven major overseas distributors is as high as 60 US dollars, okay?

What’s even more outrageous is the factory price at Wugengtian. They are really only responsible for factory delivery!

What this means specifically is that the seven major overseas distributors purchase goods from Wugengtian Pharmaceutical Group. Wugengtian Pharmaceutical Group is only responsible for getting the products out of the warehouse, and all other matters are left to the seven major overseas distributors to handle.

This includes getting it from Wugengtian to customs, then passing customs inspection, relevant taxes, cross-border transportation, etc. All these things need to be handled by the seven major overseas distributors themselves.

That is why we say that Wugengtian’s ex-factory price to the seven major overseas distributors is really a completed transaction once it is ‘ex-factory’.

"If the lupus erythematosus project is successful, we will produce the corresponding drugs at five o'clock in the morning. In view of the differences in sales areas between the five major domestic distributors and the seven major overseas distributors, we will set sales prices that are in line with the corresponding areas." An Wuyang said seriously.

Xu Le replied, "I understand!"

Then Xu Le looked at Chen Hongzhi, and Chen Hongzhi also understood what Xu Le meant.

What Xu Le meant was that although An Wuyang indicated that the corresponding drugs might be sold at a relatively low price in China, the prices of drugs in overseas regions would definitely be higher.

So as long as the drug for lupus erythematosus is successfully developed, we will definitely make money!

As for failure.
Take a gamble!
Chen Hongzhi took a deep breath and said with determination, "Brother Wuyang, our family wants to invest in the lupus erythematosus project. We want a 10% share. Is that okay?"

An Wuyang did not agree directly, nor did he refuse directly. He responded, "Since Brother Hongzhi has the intention to invest, I am prepared to split the equity of the lupus erythematosus project into two."

"First, we at Wugengtian hold 40% of Class A shares, and the remaining 60% are Class B shares." An Wuyang explained.

"The dividend rights of Class A shares and Class B shares are the same, but in terms of voting rights, Class A shares are equal to 15 votes of Class B shares. This means that as we hold 90.91% of Class A shares, we will obtain approximately % of the voting rights." An Wuyang laid the problem out clearly.

"To put it simply, the lupus project is still under the absolute control of us at Wugengtian, and we at Wugengtian can decide any matters concerning the lupus project." An Wuyang added.

Chen Hongzhi responded first, "We in the Chen family agree to this request. After all, you five geniuses are experts in the medical field, and we don't understand these things either."

"Us too!" Lin Qianli seconded.

Xu Le replied with a smile, "Just sharing the money, but not doing the work, who can refuse such a good thing?"

Chen Hongzhi added, "How are you going to allocate the 60% investment share?"

An Wuyang shook his head. "I will contact Brother Shiyu and Brother Guanghao later. How about you two discuss it with each other?"

How could An Wuyang divide the cake on behalf of these people?
Although An Wuyang is very capable in dividing the cake, sometimes dividing the cake requires strength. Will An Wuyang divide the cake between the Didu circle and the Shengqing circle?
Then if you give more to someone and less to someone else, wouldn't that offend people?
Dividing the cake is a good thing, but if it is not divided properly it becomes a bad thing.

So An Wuyang wisely chose to transfer the distribution rights. He only made the first cut, taking back the small portion that belonged to Wu Gengtian and giving away a larger portion.

"Regarding the lupus erythematosus project, we at Wugengtian have also initially planned to invest 10 billion Xia Guoyuan. According to this investment scale, if the % of Class B shares are not used up, we at Wugengtian will unconditionally buy them back." An Wuyang determined the investment amount, allowing everyone to consider how the cake should be divided.

Chen Hongzhi looked at Lin Qianli and Xu Le, "Shall we three discuss this?"

This means that in the imperial capital circle, the three of them directly swallowed up the corresponding investment amount.

However, Gu Mingyue suddenly spoke up, "Chen Hongzhi, do you want to take all the benefits for yourself again?"

Chen Hongzhi frowned immediately, "You guys want to participate too?"

"No?" Gu Mingyue asked back.

"Of course, of course." Chen Hongzhi was a little speechless. Why did Gu Mingyue come again?
"However, you have also heard that the success rate of this lupus project is very low!" Chen Hongzhi reminded.

"So what?" Gu Mingyue asked back.

(End of this chapter)